Uncle Kory Foundation
EIN 464485313Total Given 2017–2024
$2.3M
59 grants · $282K avg/year
based on 8 yrs of IRS 990-PF records on file
$100K+/yr
local funder
capacity
$50K
typical mid grants · $8K–$50K
grant size
39%
supporter · 11/28 multi-year
repeat
$1.0M
Assets (2024)
28
Distinct Recipients
About
As explained below, the Foundation has no plans for dissolution. This statement is submitted to report the distribution of certain assets during the year. The distributions resulted in a substantial contraction of assets. The following information is submitted in accordance with Treasury Regulation Section 1.6043-3(a)(1) and the Form 990-PF instructions: During the taxable year ending December 31, 2021, the Foundation made distributions from assets from sources other than current income. Collectively, the distributions in excess of current income totaled $212,000. This amount represents 25% or more of the Foundation's net assets of $610,810 (as measured by fair market value) at the beginning of the Foundation's taxable year ending December 31, 2021. Although the Foundation technically experienced a substantial contraction and has no plans for dissolution. The Foundation made distributions of cash to the grantees listed in the attachment to Part XV, Line 3a; each such grant was made solely for the charitable purpose specified therein.
Focus Areas
Application Information
Accepts Unsolicited Proposals
No — Preselected Only
Phone
(800) 839-1754
Financial Trends
Giving Over Time
Total Assets Over Time
View financial data as table
| Year | Total Giving | Total Assets | Revenue | Grants |
|---|---|---|---|---|
| 2017 | $301K | $572K | $340K | 9 |
| 2020 | $390K | $611K | $483K | 7 |
| 2021 | $212K | $505K | $197K | 8 |
| 2022 | $800K | $398K | $909K | 16 |
| 2023 | $121K | $762K | $571K | 8 |
| 2024 | $435K | $1.0M | $845K | 11 |
Grant Size Distribution
Based on 59 grants on record
Minimum
$500
25th Pctl
$8K
Median
$50K
Average
$38K
75th Pctl
$50K
Maximum
$150K
Geographic Distribution
Officers & Directors
HG
Heath H Gregory
6+ yrs
President, Dir, Sec, Treasurer
Leadership
AG
Amanda H Gregory
6+ yrs
Vice President, Dir
Leadership
AG
Amanda H Gregory
6+ yrs
Vice President, Dir
Leadership
HG
Heath H Gregory
6+ yrs
President, Dir, Sec, Treasurer
Leadership
AG
Amanda H Gregory
6+ yrs
Vice President, Dir
Leadership
HG
Heath H Gregory
6+ yrs
President, Dir, Sec, Treasurer
Leadership
AG
Amanda H Gregory
6+ yrs
Vice President, Dir
Leadership
HG
Heath H Gregory
6+ yrs
President, Dir, Sec, Treasurer
Leadership
HG
Heath H Gregory
6+ yrs
President, Dir, Sec, Treasurer
Leadership
AG
Amanda H Gregory
6+ yrs
Vice President, Dir
Leadership
AG
Amanda H Gregory
6+ yrs
Vice President / Dir
Leadership
HG
Heath H Gregory
6+ yrs
President / Dir / Sec / Treasurer
Leadership
Grants Awarded (59 total)
| Purpose | ||||
|---|---|---|---|---|
| The Ucla Foundation | Los Angeles, CA | $150,000 | to advance research in preclinical studies of a novel brain-penetrant epidermal growth factor receptor (EGFR)... | 2020 |
| The Ucla Foundation | Pasadena, CA | $150,000 | to conduct preclinical studies of a novel brain-penetrant epidermal growth factor receptor (EGFR) inhibitor and... | 2022 |
| Beckman Research Institute of the City of Hope | Duarte, CA | $50,000 | To support the research project: Overcoming Resistance to CAR T Immunotherapy with CBP/-catenin Antagonists ICG-001... | 2020 |
| Duke University | Durham, NC | $50,000 | Research project: Synthetic lethal strategies for targeting ATRX deficiency and the Alternative Lengthening of... | 2020 |
| The University of Texas Md Anderson Cancer Center | Houston, TX | $50,000 | Project FP00009152 - Repurposing Migraine Treatments for DIPG - 2nd year funding | 2020 |
| The University of Texas Md Anderson Cancer Center | Houston, TX | $50,000 | Epigenetic Regulation in Pediatric High-Grade GlioMAS | 2020 |
| Mayo Clinic | Rochester, MN | $50,000 | Research Project: TARGETING THE MALIGNANT INTERACTION BETWEEN GLIOBLASTOMA AND THE SUBVENTRICULAR ZONE | 2021 |
| Regents of the University of Colorado | Denver, CO | $50,000 | Research project: PTEFb-dependent transcriptional reorganization in the glioma adaptive response to radiotherapy | 2021 |
| Tel Aviv University | Tel Aviv, None | $50,000 | Research project: Targeting Astrocyte Metabolic Reprogramming in Glioblastoma | 2021 |
| The University of Texas Md Anderson Cancer Center | Houston, TX | $50,000 | Research project: Microbial-Inspired STING Activation for Glioblastoma Immunotherapy | 2021 |
| American Brain Tumor Association | Chicago, IL | $50,000 | Funding of Discover Grant | 2022 |
| City of Hope | Duarte, CA | $50,000 | Engineering inhibitors of the ERKS axis proteins for glioblastoma treatment | 2022 |
| Cornell University - Weill Cornell Medicine | New York, NY | $50,000 | for the research project, "Targeting CAFs to sensitize irradiated glioblastoma to PD-1 blockade" | 2022 |
| Duke University | Durham, NC | $50,000 | Research project: Synthetic lethal strategies for targeting ATRX deficiency and the Alternative Lengthening of... | 2022 |
| Johns Hopkins University | Baltimore, MD | $50,000 | Alpha-particle radiotherapy for glioblastoma | 2022 |
| Mayo Clinic | Rochester, MN | $50,000 | TARGETING THE MALIGNANT INTERACTION BETWEEN GLIOBLASTOMA AND THE SUBVENTRICULAR ZONE - 2nd year funding | 2022 |
| Society for Neuroscience | Los Angeles, CA | $50,000 | Characterizing PTPRZ1 Mechanism in Cancer as a Therapeutic Target | 2022 |
| The Regents of Ucsf | San Francisco, CA | $50,000 | Developing Multimodal Deep Learning for Outcome Prediction in Glioblastoma Patients After Radiation Therapy | 2022 |
| The University of Texas Md Anderson Cancer Center | Houston, TX | $50,000 | Repurposing Migraine Treatments for DIPG - 4th year funding | 2022 |
| The University of Texas Md Anderson Cancer Center | Houston, TX | $50,000 | Repurposing Migraine Treatments for DIPG - 3rd year funding | 2022 |
| The University of Texas Md Anderson Cancer Center | Houston, TX | $50,000 | Epigenetic Regulation in Pediatric High-Grade Gliomas - 2nd Year Funding | 2022 |
| University of Southern California | Los Angeles, CA | $50,000 | BRAIN CANCER RESEARCH | 2023 |
| University of Southern California | Los Angeles, CA | $50,000 | THE ROLE OF GABA TRANSAMINASE IN MEDULLOBLASTOMA LOCAL RECURRENCE AND ITS POTENTIAL AS A THERAPEUTIC TARGET IN... | 2024 |
| Cornell University - Weill Cornell Medicine | Ithaca, NY | $50,000 | TO FUND PROJECT "REGULATION OF MYELOID CELLS BY FATTY ACID METABOLISM IN IRRADIATED GLIOBLASTOMA." | 2024 |
| City of Hope | Duarte, CA | $50,000 | FUNDING PROJECT ADVANCING IL13RA2-CAR T CELL THERAPY AGAINST GLIOBLASTOMA BY ENHANCING IFNSIGNALING | 2024 |